136 related articles for article (PubMed ID: 11789762)
21. Prognostic impact of vascular invasion and standardization of its evaluation in stage I non-small cell lung cancer.
Hamanaka R; Yokose T; Sakuma Y; Tsuboi M; Ito H; Nakayama H; Yamada K; Masuda R; Iwazaki M
Diagn Pathol; 2015 Apr; 10():17. PubMed ID: 25884820
[TBL] [Abstract][Full Text] [Related]
22. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
Rubin Grandis J; Melhem MF; Gooding WE; Day R; Holst VA; Wagener MM; Drenning SD; Tweardy DJ
J Natl Cancer Inst; 1998 Jun; 90(11):824-32. PubMed ID: 9625170
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous expression of c-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome.
Koutsopoulos AV; Mavroudis D; Dambaki KI; Souglakos J; Tzortzaki EG; Drositis J; Delides GS; Georgoulias V; Stathopoulos EN
Lung Cancer; 2007 Aug; 57(2):193-200. PubMed ID: 17442448
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer.
Pollán M; Varela G; Torres A; de la Torre M; Ludeña MD; Ortega MD; Pac J; Freixenet J; Gómez G; Sebastián F; Díez M; Arrabal R; Canalís E; García-Tirado J; Arnedillo A; Rivas JJ; Minguella J; Gómez A; García M; Aragonés N; Pérez-Gómez B; López-Abente G; González-Sarmiento R; Rojas JM
Int J Cancer; 2003 Dec; 107(5):781-90. PubMed ID: 14566828
[TBL] [Abstract][Full Text] [Related]
25. Clinical and molecular predictors of recurrence in stage I non-small cell lung cancer.
Starnes SL; Pathrose P; Wang J; Succop P; Morris JC; Bridges J; Kupert EY; Anderson M
Ann Thorac Surg; 2012 May; 93(5):1606-12. PubMed ID: 22440368
[TBL] [Abstract][Full Text] [Related]
26. ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery.
Baiocchi G; Lopes A; Coudry RA; Rossi BM; Soares FA; Aguiar S; Guimarães GC; Ferreira FO; Nakagawa WT
Int J Colorectal Dis; 2009 Sep; 24(9):1059-68. PubMed ID: 19390858
[TBL] [Abstract][Full Text] [Related]
27. Molecular profile of advanced-stage transitional cell carcinoma of the ovary.
Gershenson DM; Baker VV; Price JE; Hung MC; El-Naggar AK; Tortolero-Luna G; Silva EG
Am J Obstet Gynecol; 1997 Jul; 177(1):120-5. PubMed ID: 9240594
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
[TBL] [Abstract][Full Text] [Related]
29. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
Guddo F; Giatromanolaki A; Koukourakis MI; Reina C; Vignola AM; Chlouverakis G; Hilkens J; Gatter KC; Harris AL; Bonsignore G
J Clin Pathol; 1998 Sep; 51(9):667-71. PubMed ID: 9930070
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
32. Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-alpha, and c-erb B-2 in nephroblastoma.
Ghanem MA; Van Der Kwast TH; Den Hollander JC; Sudaryo MK; Mathoera RB; Van den Heuvel MM; Noordzij MA; Nijman RJ; van Steenbrugge GJ
Cancer; 2001 Dec; 92(12):3120-9. PubMed ID: 11753991
[TBL] [Abstract][Full Text] [Related]
33. Expression of the ErbB family of receptors in ovarian cancer.
Scoccia B; Lee YM; Niederberger C; Ilekis JV
J Soc Gynecol Investig; 1998; 5(3):161-5. PubMed ID: 9614647
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
35. Risk of recurrence in patients with surgically resected stage I non-small cell lung carcinoma: histopathologic and immunohistochemical analysis.
Poleri C; Morero JL; Nieva B; Vázquez MF; Rodríguez C; de Titto E; Rosenberg M
Chest; 2003 Jun; 123(6):1858-67. PubMed ID: 12796161
[TBL] [Abstract][Full Text] [Related]
36. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptors in non-small cell lung cancer.
Veale D; Ashcroft T; Marsh C; Gibson GJ; Harris AL
Br J Cancer; 1987 May; 55(5):513-6. PubMed ID: 3038157
[TBL] [Abstract][Full Text] [Related]
38. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer.
Taillade L; Penault-Llorca F; Boulet T; Fouret P; Michiels S; Taranchon E; Mountzios G; Validire P; Domont J; Girard P; Grunenwald D; Le Chevalier T; Soria JC
Ann Oncol; 2007 Jun; 18(6):1043-50. PubMed ID: 17355950
[TBL] [Abstract][Full Text] [Related]
40. Expression of c-erbB-2 protein and epidermal growth receptor in endometrial carcinomas. Correlation with clinicopathologic and sex steroid receptor status.
Wang D; Konishi I; Koshiyama M; Mandai M; Nanbu Y; Ishikawa Y; Mori T; Fujii S
Cancer; 1993 Nov; 72(9):2628-37. PubMed ID: 8104681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
